We are live on ! Find out more
STLN

Starling Oncology Institute, Inc. Common Stock
STLN

50 hedge funds and large institutions have $261M invested in Starling Oncology Institute, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

31.21% more ownership

Funds ownership: 82.55% → 113.76% (+31%)

27% more capital invested

Capital invested by funds: $205M → $261M (+$55.6M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 49 → 50 (+1)

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
13
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$53.3M
2
DKCM
Davidson Kempner Capital Management
New York
+$11.1M
3
PWAM
Park West Asset Management
California
+$7.98M
4
TAL
TIG Advisors LLC
New York
+$6.26M
5
KLC
Kent Lake Capital
Nevada
+$5.79M

Top Sellers

Rank Fund Capital Flow
1
SRCM
Sage Rock Capital Management
New York
-$4.77M
2
ECM
Element Capital Management
New York
-$2.67M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$2.62M
4
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.16M
5
KC
Kepos Capital
New York
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
$2.35M – – –
BCM
27
Beryl Capital Management
California
$1.97M +$2.11M +197,924 New
CCA
28
Castle Creek Arbitrage
Colorado
$1.63M – – –
SFM
29
Sphera Funds Management
Israel
$1.62M +$1.73M +162,759 New
DAM
30
Deltec Asset Management
New York
$996K – – –
PC
31
Periscope Capital
Ontario, Canada
$996K – – –
LA
32
Linden Advisors
New York
$970K -$29.1K -2,729 -3%
TCM
33
Tenor Capital Management
New York
$896K -$107K -10,000 -10%
FTCM
34
First Trust Capital Management
Illinois
$686K – – –
RA
35
Ramius Advisors
New York
$655K +$700K +65,724 New
OP
36
Omni Partners
United Kingdom
$615K -$1.08M -101,638 -62%
DCM
37
Dupont Capital Management
Delaware
$498K – – –
QGA
38
Q Global Advisors
Texas
$498K +$533K +50,000 New
PSAMP
39
P. Schoenfeld Asset Management (PSAM)
New York
$494K -$537K -50,404 -50%
Baird Financial Group
40
Baird Financial Group
Wisconsin
$458K +$490K +46,000 New
CC
41
Centiva Capital
New York
$261K -$317K -29,793 -53%
Morgan Stanley
42
Morgan Stanley
New York
$250K +$256K +24,062 +2,359%
WRBC
43
W.R. Berkley Corp
Connecticut
$247K +$265K +24,848 New
AA
44
AQR Arbitrage
Connecticut
$174K -$79.9K -7,500 -30%
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
$165K -$29.3K -2,752 -14%
Citadel Advisors
46
Citadel Advisors
Florida
$144K +$154K +14,448 New
CWM
47
Centric Wealth Management
Illinois
$100K – – –
EAM
48
Exos Asset Management
New York
$50K +$53.3K +5,000 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$25K +$23.4K +2,200 +733%
Hudson Bay Capital Management
50
Hudson Bay Capital Management
Connecticut
– -$2.62M -242,676 Closed
1
2
3

STLN Hedge Fund Activity: Q1 2021 in Review

50 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Institute, Inc. Common Stock (STLN) for Q1 2021, worth a combined $261M — up 27% from $205M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new STLN positions and 8 closed out — a net gain of 1 holder — while 13 added to existing stakes and 17 trimmed.

The largest buyer was Deerfield Management, adding an estimated $53.3M. The largest seller was Sage Rock Capital Management, cutting an estimated $4.77M.

  • 50 institutional investors held Starling Oncology Institute, Inc. Common Stock (STLN) as of Q1 2021, up from 49 in Q4 2020.
  • Funds reported $261M of Starling Oncology Institute, Inc. Common Stock stock for Q1 2021, up 27% quarter-over-quarter.
  • 9 funds opened new Starling Oncology Institute, Inc. Common Stock positions in Q1 2021 and 8 closed out, a net change of +1 holder.
  • The largest Starling Oncology Institute, Inc. Common Stock buyer in Q1 2021 was Deerfield Management, an estimated $53.3M added.
  • The largest Starling Oncology Institute, Inc. Common Stock seller in Q1 2021 was Sage Rock Capital Management, an estimated $4.77M sold.

Based on aggregated 13F filings for Q1 2021.